FIG — No clear edge · mrktpulsealpha

Thesis

FIG's collapse from ~$142 to $24 is one of the most severe post-IPO resets of its cohort, caused by (1) valuation normalization from a ~$68B peak market cap, (2) lockup-driven insider supply, and (3) AI investment costs compressing margins plus guidance implying growth deceleration (Q3 guide ~36% vs Q2's 48%). The underlying business remains genuinely strong — 48% revenue growth, 82% gross margins, 136% NDR, raised FY guidance — and estimate revisions have been mildly positive, meaning this is predominantly multiple compression, not deterioration. However, even after an 80% drawdown the stock trades at ~8x forward sales and ~86-89x forward EPS, so 'dipped' does not equal 'cheap': the multiple reset may be mostly done, but the stock still prices in durable high growth while deceleration and AI-native competition remain unresolved.

Bull case

The business has never been stronger while the stock trades far below its post-IPO valuation extremes: 48% growth, 136% NDR, 82% gross margins, raised guidance, and positive revenue revisions — all at ~8x forward sales, versus the ~65x sales implied by the ~$68B peak market cap (though still above the ~5.6x it hit at the 2026 low of ~$16.9). If the Q3 'deceleration' proves to be conservative guidance sandbagging (a common post-IPO pattern) and AI features drive seat expansion and credit monetization as management claims, the next two earnings beats could force a re-rating back toward 10-12x sales (~$30-36/share). The stock has already bounced 43% off its lows and has been basing for 3 months.

Bear case

This is a repricing, not a dip: growth is decelerating (48% → guided 36%), AI costs are structurally compressing margins, AI-native design tools threaten the core franchise, lockup supply and insider selling continue, and the stock still trades at 86x forward earnings with ~80% realized vol. If Q3 prints at or below the 36% guide and gross margin slips further, the 8x sales multiple has room to compress toward mature-software levels (4-6x), implying $12-18. Last week's -16% on roughly average volume suggests the selling isn't exhausted.

What would change our mind

If Q3 2026 revenue beats the ~36% guide AND gross margin stabilizes/expands, the bear/deceleration thesis is invalidated and the dip-dislocation reading gains support
If revenue estimates get revised DOWN (they've been rising) or NDR drops materially below ~130%, the 'fundamentals intact' pillar breaks and the dip is deterioration
If the stock breaks below the 2026 low (~$16.9) on heavy volume post-earnings, the basing thesis fails

**FIG's post-IPO collapse and partial rebound.** The key visual is the round trip from roughly $142 to $24, showing a severe valuation reset with only a modest 2026 rebound—evidence that the dip was real but not clearly cheap.

Since publication vs SPY · closed horizons are frozen

1 weekfinal

+6.1%

+5.0% raw

1 monthrunning

-6.4%

-6.2% raw

3 monthsrunning

-6.4%

-6.2% raw

6 monthsrunning

-6.4%

-6.2% raw

The full research everything the view rests on

Direct answer to the question asked

Figma has dipped by any historical standard: -80.7% max drawdown, 72% below its 52-week high, -56% over 1 year, and now below its $33 IPO price — driven by post-IPO valuation reset, lockup supply, and AI-related margin/deceleration fears, not by fundamental collapse (Q2 2026 revenue +48%, FY guidance raised to ~$1.47B, NDR 136%). But at ~8x forward sales and ~86x forward EPS with growth guided to decelerate and AI costs compressing margins, the dip reads more like a repricing than a dislocation. The washout appears to have bottomed earlier in 2026 (up 43% off its lows, +11% in 3 months), but I don't see a clear edge at $24.

Where the edge would come from

What the price assumes

At $24 (~$11.8B market cap), the market is pricing roughly 8x FY2026 guided sales (~$1.46B) and ~86x forward EPS — expectations of continued 30%+ growth with margin expansion delayed by AI infrastructure spend. The price no longer assumes hyper-growth perfection (as it did at $142), but it still assumes Figma successfully monetizes AI (Figma Make, AI credits) and defends share against AI-native design tools.

Why the market may be wrong

Consensus may be wrong in either direction on the deceleration question: bears extrapolate the Q3 guide (36%) into a structural slowdown driven by AI-native competition, yet NDR of 136% and a $40M guidance raise suggest expansion revenue is intact and management may be guiding conservatively post-IPO. Conversely, bulls treating this as 'just multiple compression' may underweight that AI costs are a structural, recurring margin headwind, not a one-time investment cycle — the 16% earnings-linked selloff on margin news shows the market is only beginning to price that.

The one thing to watch

The variable that matters now isn't revenue growth — it's whether AI spend is capex-like (one-time, margin-accretive later) or COGS-like (permanently lower structural margins). Figma's 82% gross margin is the core asset; if AI inference costs migrate into COGS as AI features become table stakes, the 8x sales multiple de-rates regardless of growth. Watch gross margin trajectory quarter to quarter, not the top line.

Key evidence (7)

Price: $24.12 as of 2026-09-04, -72.4% below 52w high, +43.2% above 52w low, max 1y drawdown -80.7%, 1y return -55.8% vs SPY +18.7% [market data]
FY2025 (SEC XBRL): revenue $1.056B, gross margin 82.4%, GAAP net loss -$1.25B (diluted EPS -$3.71, heavily IPO/SBC-driven) [T1 SEC]
Q2 2026 (reported Aug 5, 2026): revenue $370M +48% y/y, adjusted EPS $0.08 beat, FY2026 guidance raised ~$40M to $1.463-1.467B, NDR 136% [T1 IR / T3 Morningstar]
Q3 2026 guide implies ~36% growth — deceleration vs Q2's 48%; Reuters reported a 16% after-hours drop on AI-driven cost/margin compression despite the raise [T2 Reuters]
Insider selling: GC Brendan Mulligan sold ~211.6K shares Aug 28 under a 10b5-1 plan plus Form 144 for ~109K shares filed ~Sep 3 [T1 SEC filings via T4 aggregators]
Valuation: forward P/E ~86-89x on FY26 EPS consensus ~$0.24; recent observed forward P/E range ~66-141x; estimate revisions net positive for revenue over 3 months [T3 MarketWatch / T4 sources]
Data caveat: one fundamentals pull showed stale FY26 revenue consensus of ~$1.30B vs company guidance of $1.46B — treat guidance as authoritative

Catalysts and risks

Catalysts

Q3 2026 earnings (~November 2026): the deceleration guide (~36%) is the key test — a beat vs. guide reframes the narrative
Quarterly gross margin prints: evidence on whether AI costs are one-time or structural
Further lockup expiry tranches and insider Form 144/Form 4 filings
AI product monetization metrics (Figma Make adoption, AI credit revenue disclosure)
Competitive moves from AI-native design tools and Adobe's response

Risks

Growth deceleration proves structural rather than conservative guidance
AI infrastructure costs permanently impair the 82% gross margin profile
Residual lockup/insider supply overhang caps rallies
AI-native competitors erode Figma's design-tool moat faster than expected
Extreme volatility (80%+ annualized) makes position sizing difficult and 3-6 month outcomes near-random
Evidence residue: timing of the most recent -16% weekly move is weakly sourced — may reflect items not captured in this bundle

What to watch

Gross margin trajectory each quarter — the single most informative line item
Q3 print vs the 36% guide; magnitude of any beat
NDR trend (136% last reported)
Form 144/Form 4 cadence from insiders beyond scheduled 10b5-1 sales
Analyst estimate revision direction — currently mildly positive; a flip to negative would be a red flag
Volume on down-days vs up-days to gauge whether distribution is exhausted

Market snapshot when the call was made 2026-09-04

Price

Return 1w	-16.3%
Return 1m	+0.6%
Return 3m	+10.9%
Return 6m	-17.1%
Return 1y	-55.8%
From 52-week high	-72.4%
Realized vol, 20d	83.5%
SPY 3m / 1y	+4.4% / +18.6%
QQQ 3m / 1y	+2.0% / +25.0%

Technicals

FIG technicals as of 2026-09-04: last close $24.12; 20d SMA 26.45 (bullish); 50d SMA 24.17; 12d EMA 26.38; 26d EMA 25.87; RSI 14 46.7 (balanced); 20d vol 79.6%; volume x1.1 vs 20d avg

Verifier notes REVISE · opinion revised once

Unsupported claims

Bull case claims the stock trades 'at ~8x forward sales, the low end of its post-IPO range.' This is contradicted by the evidence itself: the stock is 43% above its 52-week low (~$16.9 per the planner digest), and at that low the market cap (~$8.2B on ~487M shares implied by $11.76B / $24.12) against FY26 guidance of ~$1.46B implies roughly 5.6x sales — meaningfully below today's 8x. The evidence bundle contains no historical price/sales range to support 'low end of the range,' and the computable figures cut against it.

Internal inconsistencies

Bull case says 'The stock already bottomed 43% lower' — the 43.2% figure in the evidence is the percentage the current price sits ABOVE the 52-week low, not how far below the current price the low was (the low was ~30% below $24.12). The number is inverted relative to the source data, and it clashes with the same opinion's key_evidence line, which states the 43% correctly.

Corrections applied

In bull_case, replace 'all at ~8x forward sales, the low end of its post-IPO range' with a defensible version, e.g. 'all at ~8x forward sales — far below the ~65x sales implied by the ~$68B peak market cap, though still above the ~5.6x it hit at the 2026 low' — or simply drop the range claim.
In bull_case, fix 'The stock already bottomed 43% lower' to 'The stock has already bounced 43% off its lows' (or 'bottomed ~30% below current levels') to match the market data as used elsewhere in the opinion.

Sources (16 · T1 = primary filings)

Earlier and later calls on FIG

Sep 25, 2026Business strong; stock a speculative buy.Lean bullishview changed
Sep 15, 2026Yes — but only in small size.Lean bullishview changed
Aug 23, 2026No clear edge at $27.No clear edge
Aug 14, 2026Multiple compression, not deterioration.Lean bullishview changed

Yes — massively, but not cheaply.

Thesis

Bull case

Bear case

What would change our mind

Since publication vs SPY · closed horizons are frozen

The full research everything the view rests on

What the price assumes

Why the market may be wrong

The one thing to watch

Catalysts

Risks

Price

Technicals

Earlier and later calls on FIG

Want a fresh look at FIG, or another name?